Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Erlotinib Hydrochloride × Head & Neck × Clear all

Sponsor

Cancer Type

Interventions

pembrolizumab 3 Cisplatin 3 selpercatinib 2 entrectinib 2 Carboplatin 2 trametinib 1 toripalimab 1 repotrectinib 1 pralsetinib 1 penpulimab 1 larotrectinib 1 dabrafenib 1 cabozantinib 1 Gemcitabine 1 Fluorouracil 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡